Understanding the pathophysiologic relationships (Figure 6) between insulin, glycemia, obesity, and inflammation, and how they relate to cancer may help target DM treatment more successfully (Macciò & Madeddu, 2011). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.